Elixinol Wellness Limited (ASX:EXL)

Market Cap	6.62M
Revenue (ttm)	14.96M
Net Income (ttm)	-1.72M
Shares Out	220.82M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,320
Average Volume	59,407
Open	0.0290
Previous Close	0.0300
Day's Range	0.0290 - 0.0300
52-Week Range	0.0240 - 0.0560
Beta	2.21
RSI	45.01
Earnings Date	Feb 24, 2025

About Elixinol Wellness

Elixinol Wellness Limited, through its subsidiaries, engages in the manufacture and distribution of hemp derived nutraceuticals, skincare, and food products in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2017
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: EXL

Financial Performance

In 2024, Elixinol Wellness's revenue was 14.96 million, an increase of 80.87% compared to the previous year's 8.27 million. Losses were -1.72 million, -77.06% less than in 2023.